Reversing Blindness and Restoring Vision with Optogenetics
🗓 Date: Tuesday, October 28, 2025
⏰ Time: 3:00 PM GMT (9:00 PM Bangladesh Standard Time)
📍 Format: Virtual (1 Hour)
Registration for this exclusive Nature Conference is now open for the final time. The event is being organized to highlight groundbreaking progress in optogenetic therapies designed to reverse blindness. Nature Conferences
It is estimated that around 2 million people worldwide are affected by retinitis pigmentosa — a group of genetic disorders in which the retina’s light-sensing cells (rods and cones) are destroyed or lose responsiveness to light. Although most treatments are aimed at slowing down the deterioration of sight, research efforts are being directed toward restoring lost vision through gene therapy that enables retinal cells to regain light sensitivity.
During this virtual session, insights will be shared regarding:
-
The progress achieved toward the reversal of blindness
-
The clinical trials currently being conducted
-
The challenges anticipated in translating research into clinical applications
Speakers:
-
Botond Roska, Co-director, Institute of Molecular and Clinical Ophthalmology Basel, Switzerland
-
Zhuo-Hua Pan, Scientific Director, Ligon Research Center of Vision, Kresge Eye Institute, Detroit, USA
Moderator:
-
Richard Hodson, Senior Editor, Supplements, Nature
🎟 Free registration is being offered, and all registrants will be granted on-demand access following the live broadcast.
Presented by: Nature Outlook
Produced with support from: Astellas
Publisher: Springer Nature
A visionary discussion will be conducted to explore how modern science is being used to bring light back to those living in darkness.
